Gray Matter Volumes in Obsessive-Compulsive Disorder Before and After Fluoxetine or Cognitive-Behavior Therapy: A Randomized Clinical Trial
Year: 2011
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Neuropsychopharmacology
DOI: 10.1038/npp.2011.250
Authors: Marcelo Queiroz Hoexter, Fábio Luis de Souza Duran, Carina Chaubet D'Alcante, Darin Dean Dougherty, Roseli Gedanke Shavitt, Antonio Carlos Lopes, Juliana Belo Diniz, Thilo Deckersbach, Marcelo Camargo Batistuzzo, Rodrigo Affonseca Bressan, Euripedes Constantino Miguel, Geraldo Filho Busatto
Language: English
Subfield: Clinical Psychology
Field: Psychology
Domain: Social Sciences
Open Access status: green
Funders: Eli Lilly and Company, AstraZeneca, National Alliance for Research on Schizophrenia and Depression, Massachusetts Medical Society, University of Oxford, Deutsche Forschungsgemeinschaft, Fundação de Amparo à Pesquisa do Estado de São Paulo, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, H. Lundbeck A/S, National Institutes of Health, Agency for Healthcare Research and Quality, National Institute on Aging, National Institute of Mental Health, National Institute on Drug Abuse, Division of Graduate Education, Janssen Pharmaceuticals
Award: G4968863399
OpenAlex ID: W2015036471
